• Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy (Companion Faculty Lecture)

  • 2025/04/24
  • 再生時間： 32 分
  • ポッドキャスト

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy (Companion Faculty Lecture)

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Featuring a slide presentation and related discussion from Dr Adam M Brufsky, including the following topics:

    • Mechanism of action of and long-term data with CDK4/6 inhibitors in the management of metastatic breast cancer (mBC) (0:00)
    • Comparing safety profiles of CDK4/6 inhibitors (9:49)
    • Role of CDK4/6 inhibitors in therapy for older patients with mBC (24:06)
    • Real-world evidence with CDK4/6 inhibitors (27:31)

    CME information and select publications
    続きを読む 一部表示

あらすじ・解説

Featuring a slide presentation and related discussion from Dr Adam M Brufsky, including the following topics:

  • Mechanism of action of and long-term data with CDK4/6 inhibitors in the management of metastatic breast cancer (mBC) (0:00)
  • Comparing safety profiles of CDK4/6 inhibitors (9:49)
  • Role of CDK4/6 inhibitors in therapy for older patients with mBC (24:06)
  • Real-world evidence with CDK4/6 inhibitors (27:31)

CME information and select publications
続きを読む 一部表示

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy (Companion Faculty Lecture)に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。